Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Andrew Wong
Period: Reporting periods mapped to calendar 2024 Q4 – 2026 Q2 (7 quarters).
- Questions
- 18on tracked calls
- Challenge rate
- 11%2 of 18 questions
- Companies
- 2questioned at least once
- Reporting periods
- 7with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 18 of 18 questions from 2 companies
CFCF Industries12 questions · 7 reporting periods · 2 of 12 challenging
Calendar 2026 Q2
what is driving that disconnect, and then what can you do at CF to kind of close that gap?
Show response
Bohn argued CF is misvalued against chemical peers, citing almost 40% higher production volume and almost 60% lower share count, and pledged continued buybacks while shares are undervalued.
Calendar 2026 Q1
does that change how you think about expansion? Could you accelerate plans to add more capacity?
Show response
Chris said higher return profiles on projects in motion or under consideration. Blue Point site expandable over time with second plant seeing efficiencies from existing infrastructure including dock, tanks, and offsites. Nothing imminent on expansion but evaluating. Capital allocation philosophy unchanged with excess free cash flow expected to go to share repurchases or dividends.
Calendar 2025 Q4
I just wanted to ask about the pace of spending at the Blue Point project, it looked like some of the project might have been pushed now
Show response
Chris confirmed total Blue Point cost unchanged at $3.7B but payment timing updated as procurement progresses. Highlighted Slide 15 showing annual cash outflows manageable against $1.8B free cash flow, enabling continued buybacks alongside growth CapEx. CF took 40% interest specifically to maintain capital allocation flexibility.
does it make sense that we'll see a larger complex there? And is there a timing where it's more efficient to like so that you have workers that are already working at Blue Point to move to the seco...
Show response
Chris confirmed site can hold up to 5 world-scale ammonia plants. Common infrastructure provides synergies reducing cost of subsequent plants. Focus currently on first plant with timing for second dependent on market dynamics and module yard learnings. Long-term S&D tightening expected to create organic growth opportunities.
Calendar 2025 Q3
Would there be any consideration for using debt to fund Bluepoint and then maybe using the cash flows and the cash generation to buy back shares?
Show response
Tony argued against leveraging up citing need for balance sheet flexibility in commodity business, referencing Waggaman cash acquisition as example. Chris noted cash flow generation is sufficient to fund both Blue Point and significant buybacks simultaneously. Greg highlighted $1.3B returned to shareholders plus $700M CapEx with $1.8B still on hand.
SG&A looked still just a little bit elevated for the quarter, obviously, not hugely, but just curious if there's anything there
Show response
Greg attributed SG&A to bonus accrual catch-up. Non-gas ammonia costs elevated by increased purchased tons from Trinidad and UK at market prices, but these contributed to ammonia segment gross margin dollars being up 30% year-over-year.
Calendar 2025 Q2
With the implementation of CBAM, can you just talk about how you see that impacting the markets, both in Europe and globally
Show response
Chris outlined CBAM transitional phase active with full implementation January 2026. Donaldsonville low-carbon ammonia gets roughly $25/mt benefit initially, growing to $100/mt by 2030. Tony noted CF already seeing demand and premium for low-carbon product before CBAM kicks in.
What's your view on how a Russia and Ukraine truce or some sort of p-settlement could impact on natural gas prices and also on the nitrogen market?
Show response
Bert argued Nord Stream rebuild unlikely, European gas reliance on Russia not returning. Expected US gas exports to rise from 15 Bcf to mid-20s. Chris added European curtailments expected to continue regardless of peace outcome given rebuild timelines.
Calendar 2025 Q1
to clean ammonia pricing when you are discussing your potential customers. I'm just curious like what factors you talked about
Show response
Bert described carbon premium pricing as separate line item starting at lower levels then growing with demand competition. Customers across ag corn value chain and industrial intermediates showing interest in scope emissions improvements.
if the EU implements tariffs on Russian product, what's your thought on how like UAN trade flows range?
Show response
Bert noted CF exports UAN to EU and UK with established partners. Russian UAN volumes to US likely stable under current zero-tariff regime. Noted Russia balancing between UAN, urea, ammonia, and ammonium nitrate end molecules.
Calendar 2024 Q4
CapEx has gone up quite significantly from the beginning of when we started seeing some of the numbers like last year
Show response
Tony noted the required ammonia price of $450/mt is below current market levels. Chris highlighted ATR technology gives 10% more production and 50% more carbon capture vs SMR.
how would you compare the project versus potentially using that cash for more of buybacks
Show response
Tony defended the dual strategy citing 1-10 year TSR outperformance vs peers. Emphasized deploying capital in core ammonia operations plus buybacks for excess capital.
MOSMosaic Company (The)6 questions · 6 reporting periods · 0 of 6 challenging
Calendar 2026 Q2
$705 per long ton was pretty -- it was well below spot prices. Can you just kind of talk about how that came about
Show response
Bodine credited the $705 settlement, below spot, to a symbiotic Gulf Coast refiner relationship valuing Mosaic's ratable sulfur baseload. He said ramp-up would take weeks, not months, once sulfur returns, having prioritized asset health.
Calendar 2025 Q4
phosphate demand, it's been down pretty significantly for the past four years, but yields, the crop yields have still been pretty strong
Show response
Bodine confirmed CVD sunset review starting April with duties remaining in place through the process. Evaluating participation needs. Wang noted the 14-15% drop in US phosphate shipments was concentrated in fall application, meaning yield impact would show in the current crop. Precision agriculture enabling rate cuts but phosphorus depletion cannot be sustained without replenishment.
Calendar 2025 Q3
Is that now 1.8 million tonnes? Or is that just for the very near-term upcoming quarter and then there's longer-term upside
Show response
Bodine confirmed 1.8M ton trailing rate is proven floor with upside commitment to 2M tons. Luciano provided cost detail: Aug-Sept conversion cost under $120/ton, with rule of thumb $7/ton reduction per additional 100K tons quarterly. At 2M ton run rate, cost would be $100-$105. Phosphate EBITDA could improve 50%+ if production increased 25% due to operating leverage.
Calendar 2025 Q2
what has Mosaic done to harden the assets against any potential weather disruptions
Show response
Bodine described motor control center elevation above flood stage, wind-hardening modifications to warehouses, and gypsum stack freeboard management for hurricane season. Explained New Wales gypsum pump replacements were discovered only when pushing to full rates as rock quality changes increased gypsum output per ton. Confirmed no similar bottlenecks identified at other facilities.
Calendar 2025 Q1
how the S&D plays out over the next, say, like six to 12 months as production improves. Does that impact the market balances and pricing
Show response
Bodine stated incremental Mosaic production will be absorbed by pent-up Indian demand (up 40% YoY to 6.4M tons). Wang explained India needs 2 million tons for Kharif season with only 300K tons secured. Some US demand may shift to Brazil if affordability tightens but overall market remains tight.
Calendar 2024 Q4
what other assets might be considered. You've mentioned Carlsbad. Is there anything else that might be notable that we should be thinking about
Show response
Bodine confirmed Carlsbad process is active with potential news in coming weeks but deferred specifics to March Analyst Day. Ciani said Ma'aden shares could be partially monetized before lock-up but not the full position.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| CF CF Industries | 12 | 17%2 of 12 questions |
| MOS Mosaic Company (The) | 6 | 0%none of 6 questions |
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2024 Q4 | 3 | 33%1 of 3 questions | 2 |
| 2025 Q1 | 3 | 0%none of 3 questions | 2 |
| 2025 Q2 | 3 | 0%none of 3 questions | 2 |
| 2025 Q3 | 3 | 0%none of 3 questions | 2 |
| 2025 Q4 | 3 | 0%none of 3 questions | 2 |
| 2026 Q1 | 1 | 0%none of 1 question | 1 |
| 2026 Q2 | 2 | 50%1 of 2 questions | 2 |
- 2024 Q43 questions · challenge rate 33% (1 of 3 questions) · 2 companies
- 2025 Q13 questions · challenge rate 0% (none of 3 questions) · 2 companies
- 2025 Q23 questions · challenge rate 0% (none of 3 questions) · 2 companies
- 2025 Q33 questions · challenge rate 0% (none of 3 questions) · 2 companies
- 2025 Q43 questions · challenge rate 0% (none of 3 questions) · 2 companies
- 2026 Q11 question · challenge rate 0% (none of 1 question) · 1 company
- 2026 Q22 questions · challenge rate 50% (1 of 2 questions) · 2 companies
Topics
Topics tagged on this analyst’s questions.
- Capex Investment7
- Capital Allocation4
- Competitive Dynamics4
- Supply Chain4
- Cost Pressure2
- Demand2
- Regulation Policy2
- Pricing2
- Trade Tariffs1
- Margin1
Show all 13 topics
- Macroeconomic1
- Innovation & R&D1
- M&A1